Regeneron (REGN) Announces IDMC Finds Clear Efficacy for REGEN-COV in Phase 3 COVID-19 Outpatient Outcomes Trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/9/2026

1. TTAN
2. CHYM
3. BRZE
4. USO
5. QCOM
6. DYN
7. PHVS
8. NOVN:SW
9. USB
10. NVS

Go back to Regeneron (REGN) Announces IDMC Finds Clear Efficacy for REGEN-COV in Phase 3 COVID-19 Outpatient Outcomes Trial
Regeneron (NASDAQ: REGN) Delayed: 810.31 --0 (-0%)
Previous Close $810.31    52 Week High $592.36 
Open $810.31    52 Week Low $325.35 
Day High $810.31    P/E 212.68 
Day Low $810.31    EPS $3.81 
Volume 56